7775 — Daiken Medical Co Balance Sheet
0.000.00%
- ¥13bn
- ¥12bn
- ¥10bn
- 92
- 64
- 46
- 79
Annual balance sheet for Daiken Medical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 2,171 | 2,519 | 2,516 | 2,739 | 2,996 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,588 | 2,431 | 2,530 | 2,480 | 2,471 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6,273 | 6,572 | 6,639 | 6,731 | 6,985 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,225 | 4,119 | 4,070 | 3,987 | 3,931 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 10,753 | 10,921 | 11,013 | 11,006 | 11,181 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,347 | 3,151 | 3,369 | 3,340 | 2,830 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 4,571 | 4,475 | 4,416 | 3,984 | 3,665 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 6,182 | 6,446 | 6,597 | 7,022 | 7,516 |
Total Liabilities & Shareholders' Equity | 10,753 | 10,921 | 11,013 | 11,006 | 11,181 |
Total Common Shares Outstanding |